Skip to content

Comstock Inc. LODE Bioleum — Assets Current

Similar metrics at other companies

Madrigal Pharmaceuticals, Inc. logo
MDGLTotal Current Assets
$1.18B+19.7%
ProFrac Holding Corp. logo
ACDCAll Other Segments — Assets Current
$4.4M-95.4%
Nuvalent, Inc. logo
NUVLTotal Current Assets
$1.31B+20.4%
ImmunityBio, Inc. logo
IBRXTotal Current Assets
$452.95M+315%
International Tower Hill Mines logo
THMUS — Assets Current
$450.73K+1.3%
Schering-Plough logo
SGPTotal Current Assets
$253.36M

Other financials

Income statement

See full
Revenue$313.5K-60.1%
Gross profit-$286.4K-184%
Operating income-$8.9M-27.1%
Net income-$9.4M-3.2%
EPS (diluted)-$3.01-450%

Balance sheet

See full
Cash & equivalents$53.0M+212%
Total debt$257.3K-98.8%
Total equity$156.4M
Total assets$218.1M+28.6%

Cash flow

See full
Operating cash flow-$5.8M-17.3%
CapEx--100%
Free cash flow-$3.5M+2.7%

Valuation

See full
Market cap$302.13M+177%
Enterprise value$249.42M+118%
P/S279.4×+247×

Profitability

See full
Gross margin-116.4%-177pp
Operating margin-3,703.7%-7,510pp
Net margin-4,010%-13,152pp
FCF margin-462.3%-171pp

Returns & leverage

See full
Return on equity-51.5%-12.9pp
Debt / equity
Current ratio4.5×+2.1×

Where this comes from

Reported directly by Comstock Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The official record: Comstock Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Comstock Inc.'s bioleum — assets current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Comstock Inc.'s bioleum — assets current?
Comstock Inc. (LODE) reported bioleum — assets current of $4.13M in Q1 2026.
How has Comstock Inc.'s bioleum — assets current changed year-over-year?
Comstock Inc.'s bioleum — assets current decreased by 50.7% year-over-year, from $8.39M to $4.13M.
What does bioleum — assets current mean?
The total value of all assets expected to be converted into cash or consumed by the Bioleum segment within one year. This serves as a primary indicator of the segment's short-term financial health and operational scale.